Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology & Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.
You can access CPT’s Reviewer Instructions here.
In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs.
Listen and subscribe for free on iTunes and Google Play
This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.
Listen and subscribe for free on iTunes and Google Play
